Literature DB >> 16679777

Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population.

Daisuke Nishizawa1, Wenhua Han, Junko Hasegawa, Takafumi Ishida, Yukio Numata, Tadahiro Sato, Atsuko Kawai, Kazutaka Ikeda.   

Abstract

Ethanol is considered to activate the brain reward system by increasing the release of an endogenous opioid receptor ligand, beta-endorphin. The polymorphism A118G in the mu-opioid receptor gene (OPRM1) causes the amino acid change Asn40Asp and has been reported to affect the affinity of the ligand for the receptor. The association of this polymorphism with the vulnerability to alcohol dependence has been studied in many populations, but not yet in Japanese people. In the present study, we compared the frequencies of the polymorphism OPRM1 A118G between patients with alcohol dependence and healthy control subjects living in a Japanese provincial prefecture. We also genotyped a polymorphism, G1510A, in the acetaldehyde dehydrogenase 2 gene (ALDH2), in which the A allele causes poor metabolism of acetaldehyde, a major metabolite of alcohol. Both OPRM1 118G and ALDH2 1510G were significantly associated with alcohol dependence. These results suggest that OPRM1 118G in addition to ALDH2 1510G might be one of the risk factors for alcohol dependence in Japanese people. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679777     DOI: 10.1159/000093099

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  23 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 2.  Pharmacogenetics of OPRM1.

Authors:  Richard C Crist; Wade H Berrettini
Journal:  Pharmacol Biochem Behav       Date:  2013-11-05       Impact factor: 3.533

3.  Association between Opioid Receptor mu 1 (OPRM1) Gene Polymorphisms and Tobacco and Alcohol Consumption in a Spanish Population.

Authors:  Francesc Francès; Olga Portolés; Ana Castelló; Jose Antonio Costa; Fernando Verdú
Journal:  Bosn J Basic Med Sci       Date:  2015-04-25       Impact factor: 3.363

Review 4.  Alcohol dependence as a chronic pain disorder.

Authors:  Mark Egli; George F Koob; Scott Edwards
Journal:  Neurosci Biobehav Rev       Date:  2012-09-11       Impact factor: 8.989

Review 5.  Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use.

Authors:  Jessica R Barson; Irene Morganstern; Sarah F Leibowitz
Journal:  ILAR J       Date:  2012

6.  A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability.

Authors:  Peng Huang; Chongguang Chen; Stephen D Mague; Julie A Blendy; Lee-Yuan Liu-Chen
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

7.  Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol.

Authors:  Matthew S Scarnati; Andrew J Boreland; Marisa Joel; Ronald P Hart; Zhiping P Pang
Journal:  Alcohol       Date:  2020-06-17       Impact factor: 2.405

Review 8.  OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.

Authors:  Stephen D Mague; Julie A Blendy
Journal:  Drug Alcohol Depend       Date:  2010-01-13       Impact factor: 4.492

9.  The opioid peptides enkephalin and beta-endorphin in alcohol dependence.

Authors:  Ildiko Racz; Britta Schürmann; Anna Karpushova; Martin Reuter; Sven Cichon; Christian Montag; Robert Fürst; Christian Schütz; Petra E Franke; Jana Strohmaier; Thomas F Wienker; Lars Terenius; Urban Osby; Agneta Gunnar; Wolfgang Maier; Andras Bilkei-Gorzó; Markus Nöthen; Andreas Zimmer
Journal:  Biol Psychiatry       Date:  2008-06-27       Impact factor: 13.382

10.  Initial evidence of an association between OPRM1 and adolescent alcohol misuse.

Authors:  Robert Miranda; Lara Ray; Alicia Justus; Lori A Meyerson; Valerie S Knopik; John McGeary; Peter M Monti
Journal:  Alcohol Clin Exp Res       Date:  2009-10-23       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.